temasek
Tessa Therapeutics Raises US$80 Million In Funding
Proceeds from the latest funding round will be used to further develop Tessa’s solid tumor immunotherapy pipeline.
Columbia China, Temasek Join Forces To Provide Healthcare In China
Temasek is investing about US$250 million in Columbia China, enabling the latter to further expand in China through acquisitions and greenfield projects.




